Perrin, M; Ramelet, A A (2011). Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions. European journal of vascular and endovascular surgery EJVES, 41(1), pp. 117-25. London: Elsevier 10.1016/j.ejvs.2010.09.025
Full text not available from this repository. (Request a copy)The aim of this article was first to review the complex pathophysiological mechanisms responsible for symptoms and signs of primary chronic venous disease (CVD) that allow the identification of targets for pharmacological treatment. The results of CVD treatment with venoactive drugs (VADs) were emphasised and presented in the form of recommendations. The last section raises key questions to be answered to improve protocols for good clinical trials and to draw up future guidelines on these agents.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology |
UniBE Contributor: |
Ramelet, Albert-Adrien |
ISSN: |
1078-5884 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:21 |
Last Modified: |
05 Dec 2022 14:06 |
Publisher DOI: |
10.1016/j.ejvs.2010.09.025 |
PubMed ID: |
21126890 |
Web of Science ID: |
000287070800019 |
URI: |
https://boris.unibe.ch/id/eprint/7080 (FactScience: 212230) |
Actions (login required)
 |
Edit item |